Inverness acquisition
This article was originally published in The Tan Sheet
Executive Summary
Inverness Medical Innovations announces Feb. 5 it has acquired substantially all the assets of First Check Diagnostics for approximately $25 mil. in cash. First Check is the "market leader" of home testing for drugs of abuse, including marijuana, cocaine, methamphetamines and opiates, according to the press release. Waltham, Mass.-based Inverness will pay "an earn out to First Check equal to the incremental growth of the acquired products for 2007 and for the first nine months of 2008." Recently, Inverness entered into a joint venture with Procter & Gamble to develop, market and sell existing and future consumer diagnostic products (1"The Tan Sheet" Jan. 1, 2007, p. 10)...
You may also be interested in...
P&G Moves Into Consumer Diagnostics With Inverness Joint Venture
Procter & Gamble enters the consumer diagnostic products business with an agreement to form a 50/50 joint venture with Waltham, Mass.-based Inverness Medical Innovations
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.